Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis

Abstract

Rg3 inhibited the activation of microtumor vessel formation <i>in vivo</i> besides its apoptosis induction. Rg3 may be used as an adjuvant agent in the clinical HCC treatment regimen.